nck 1

TNIK-IN-3 是一种高效且口服活性的Traf2-和Nck-相互作用蛋白激酶（TNIK）抑制剂，具有对TNIK极强的选择性，其IC50值为0.026 μM。此外，TNIK-IN-3对Flt4（IC50 = 0.030 μM）、Flt1（IC50 = 0.191 μM）和DRAK1（IC50 = 0.411 μM）也显示出抑制活性。这种化合物在结直肠癌（CRC）[1]研究中具有潜在的应用价值。

TNIK-IN-1 is an inhibitor of Traf2- and Nck-interacting kinase (TNIK).

alpha-Cyperone (α-Cyperone) 与 IL-6, Cox-2, Cdc42, Nck-2, Rac1 的表达下调相关,从而能够抑制炎症反应。

AX-024 is a novel chemical compound that acts as an orally available inhibitor of the TCR-Nck interaction. Its primary mechanism of action is the selective inhibition of T cell activation triggered by TCR stimulation. With an IC50 value of approximately 1 nM, AX-024 effectively modulates cell signaling by specifically targeting SH3 domains. Additionally, AX-024 demonstrates desirable characteristics such as low acute toxicity, high potency, and excellent selectivity. Notably, it exhibits strong inhibitory effects on the production of IL-6, TNF-α, IFN-γ, IL-10, and IL-17A.

TNIK-IN-6 (Compound 9) 是一种Traf2和Nck相互作用激酶（TNIK）的抑制剂，具有0.93 nM的IC50，对神经与精神疾病具有重要影响。